4925 · HABA LABORATORIES, INC. · Financials
Market Cap
6.28B JPY
Shares
3.78M
Volume · Nov 13
900
Avg daily vol (3M)
1944
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
12.14B
+0.7%
FY2026
Net Income
760.36M
+31.9%
FY2026
Gross Margin
66.6%
-0.5pp
FY2026
Operating Margin
5.99%
+1.1pp
FY2026
Operating Cash Flow
1.24B
-23.7%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 12.14B | 12.06B | 12.32B | 12.04B | 12.91B |
| JPY | 4.05B | 3.97B | 3.92B | 3.87B | 4.11B |
| JPY | 8.09B | 8.09B | 8.4B | 8.17B | 8.79B |
| JPY | 727.37M | 589.51M | -187.77M | -609.64M | -316.73M |
| JPY | 850.05M | 635.75M | -1.84B | -548.66M | -266.96M |
| JPY | 89.69M | 59.18M | 275.32M | 159.2M | 2.08M |
| JPY | 760.36M | 576.57M | -2.12B | -707.87M | -269.03M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 756.3M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.